PHARMA
Four-Strain Seasonal Flu Vaccine Approved in Korea
The health authority of South Korea has approved the first Korean-made vaccine to cover four influenza strains.
RaQualia & Nagoya’s ITbM To Develop Circadian Rhythm Drugs
The academia-industry partnership is hoped to yield small molecule drugs that can treat symptoms of circadian clock disruption.
Sanofi & Hanmi To Partner On New Diabetes Drugs
The Sanofi-Hanmi deal centers around longer-lasting biologics, which could reduce the frequency of treatment and dosage required for diabetic patients.
WuXi & Lilly To Develop Cardiovascular Drug In China
As part of Lilly's ‘In China, For China’ strategy, the small molecule drug is intended to help the 276 million Chinese patients affected by high cholesterol.
ASLAN & Hyundai Pharm Collaborate To Develop Cancer Drug
The two companies will conduct clinical trials to assess varlitinib in the treatment of aggressive bile duct cancer, a disease prevalent in South Korea.
Using NGS To Fish Out Asian Specific Cancer Mutations
Singapore General Hospital has entered a collaboration with Thermo Fisher Scientific to perform next-generation sequencing of retrospective samples from cancer patients of Asian ancestry.
WuXi Launches Medical Device Testing Services In China
WuXi PharmaTech Laboratory Testing Division offers services including in vitro cytotoxicity, hemocompatibility and chemical characterization.
Eisai Provides Free Antiparasitic Tablets To Indonesia
Eisai has provided 151 million free diethylcarbamazine citrate tablets to the government of Indonesia for the treatment of elephantiasis.
Takeda Joins WIPO Re:Search To Accelerate R&D
Through the WIPO Re:Search consortium, Japanese pharmaceutical Takeda plans to share intellectual property assets to facilitate R&D in neglected tropical diseases.
